Creutzfeldt-Jakob disease: Australian surveillance update to March 2007
DOI:
https://doi.org/10.33321/cdi.2007.31.15Keywords:
communicable diseases, cjd, transmissible spongiform encephalopathies, Creutzfeldt-Jakob diseaseAbstract
From October 1993, prospective, national surveillance of the rare class of neurodegenerative diseases known as transmissible spongiform encephalopathies (TSEs) has been performed by the Australian National Creutzfeldt-Jakob Disease Registry. Surveillance of TSEs prior to October 1993, involved the retrospective ascertainment of TSE cases from 1970 to 1993. In this report, surveillance data for 2006 are presented in detail and compared to cumulative national TSE ascertainment as well as international experience. The higher incidence of TSEs in 2006 is not without precedent and can be attributed to higher referrals and consequent post-mortem rates. Commun Dis Intell 2007;31:194–197.
Downloads
References
Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417–421.
Brown P, Brandel JP, Preece M, Sato T. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 2006;67:389–393.
Will RG. Prion related disorders. J R Coll Physicians Lond 1999;33:311–315.
Klug GM, Boyd A, Lewis V, Douglass SL, Argent R, Lees JS, et al. Creutzfeldt-Jakob disease: Australian surveillance update to December 2005. Commun Dis Intell 2006;30:144–147.
The European and Allied Countries Collaborative Study Group of CJD (EUROCJD). Available from: http://www.eurocjd.ed.ac.uk/results.htm
Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921–925.
The National CJD Surveillance Unit. Fourteenth annual report 2005: Creutzfeldt-Jakob disease surveillance in the UK, 2006. Available from: http://www.cjd.ed.ac.uk/report14.htm
Lewis V, Hill AF, Klug GM, Boyd A, Masters CL, Collins SJ. Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles. Neurology 2005;65:113–118.
Downloads
Published
How to Cite
License
Copyright (c) 2007 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
